Severe intraocular inflammation after intravitreal injection of bevacizumab.
about
Anterior Ocular Toxicity of Intravitreous Melphalan for Retinoblastoma.Managing bevacizumab-induced intraocular inflammation.Intravitreal anti-vascular endothelial growth factor therapy for choroidal neovascularization due to Sorsby macular dystrophy.Early clinical characteristics of bacterial endophthalmitis in retinopathy of prematurity after intravitreal bevacizumab injection: A case report.Acute sterile endophthalmitis following intravitreal bevacizumab: case series.An experimental study of VEGF induced changes in vasoactivity in pig retinal arterioles and the influence of an anti-VEGF agentInfluence of drug solubility and lipophilicity on transscleral retinal delivery of six corticosteroidsOcular complications after anti-vascular endothelial growth factor therapy in Medicare patients with age-related macular degenerationToxic anterior segment syndrome after uncomplicated cataract surgery possibly associated with intracamaral use of cefuroxime.Lasting controversy on ranibizumab and bevacizumab.Prophylactic antibiotic use after intravitreal injection: effect on endophthalmitis rate.Evaluation of Aqueous Flare Levels Following Intravitreal Ranibizumab Injection for Neovascular Age-related Macular Degeneration.Drug-induced uveitisStreptococcus endophthalmitis outbreak after intravitreal injection of bevacizumab: one-year outcomes and investigative results.A cluster of presumed, noninfectious endophthalmitis after intravitreal injection of bevacizumab: long-term follow-up.Anti-vascular endothelial growth factor drugs safety and efficacy in ophthalmic diseases.Targeting the pro-angiogenic forms of VEGF or inhibiting their expression as anti-cancer strategies.Evaluation of the incidence of endophthalmitis after intravitreal injection of anti-vascular endothelial growth factor.Endophthalmitis following intravitreal injections.Suspected bacterial endophthalmitis following intravitreal anti-VEGF injection: case series and literature review.Sterile endophthalmitis after intravitreal injections.Vitreous inflammation associated with intravitreal anti-VEGF pharmacotherapy.Toxic Anterior Segment Syndrome Outbreak after Cataract Surgery Triggered by Viscoelastic Substance.Toxic anterior segment syndrome after foldable artiflex iris-fixated phakic intraocular lens implantation.Anterior uveitis after treatment of age-related macular degeneration with ranibizumab and bevacizumab: uncommon complication.
P2860
Q30368832-9CD65FF3-9F62-48E3-8B4E-0E6CE643CF04Q30463399-3DCC6FC1-D614-4CAB-96AA-86E30DD9DB71Q33720068-65F43637-7B70-46DF-915C-515590B8D5D4Q33745089-75F0A577-49B8-454E-BA89-C1C8FBB2FACEQ34182273-ED1E6A8B-1C57-40FA-9CA5-BF05419135A7Q34285235-AE1EFA0B-CCA4-4B81-B74A-3B74CE0F0CEFQ34856993-448DA2D1-11AC-484E-94A2-D28E681CCC3EQ35127099-99CAAF96-672B-4EE8-AEE3-139ADAFC97EAQ35209759-37F2D721-7413-4C38-9FDC-23CD4B958F9DQ35641933-ACF1B770-F23E-4585-AFA4-9D19670ADCBAQ35693314-1482C6E5-A138-4FD9-A7A1-85380AF79789Q35909253-DFDFDEBE-DDD4-4333-A37E-A2C71A21CA5BQ36797491-4699047F-5834-4697-9FD3-498C18CD2A6AQ36986309-FA8E7591-E013-4E4A-AA48-A171E59228BCQ37187163-619AE0EF-6722-48D5-B30B-7D61504A73CEQ37369644-09AFAA5A-B186-4835-9725-4F1DB3972324Q37705932-14004E77-6AE7-4CCC-9FD0-46A62CEEC76BQ37910660-EF74CEE8-F876-48E6-BBCF-38C79E9C121BQ37952079-2FB6B39A-3807-4D83-ACC6-D4195A7A6F8EQ38026388-91475D16-E71B-4DC0-882E-BFE3E72C1225Q38042910-71722B2C-302A-4A4A-8CFC-ADC78EC52F0EQ38168825-E6B32A79-28F3-48F5-8017-4B7363972F28Q40184575-DBC703C3-FB22-496D-ACF4-3D56F85B9D11Q41868247-616144F5-310E-4FEE-8F8C-C2052E2E061AQ42018233-CC0FD380-CE6B-4ADA-BFF1-AF3AABE246BD
P2860
Severe intraocular inflammation after intravitreal injection of bevacizumab.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh-hant
name
Severe intraocular inflammation after intravitreal injection of bevacizumab.
@en
Severe intraocular inflammation after intravitreal injection of bevacizumab.
@nl
type
label
Severe intraocular inflammation after intravitreal injection of bevacizumab.
@en
Severe intraocular inflammation after intravitreal injection of bevacizumab.
@nl
prefLabel
Severe intraocular inflammation after intravitreal injection of bevacizumab.
@en
Severe intraocular inflammation after intravitreal injection of bevacizumab.
@nl
P2093
P1433
P1476
Severe intraocular inflammation after intravitreal injection of bevacizumab.
@en
P2093
Hajime Bando
Kazuyuki Emi
Kosaku Sawada
Shigeru Sato
Shin-ichi Morita
Tatsuhiko Sato
Tomohito Oyagi
Toshihide Ikeda
P304
512-6, 516.e1-2
P356
10.1016/J.OPHTHA.2009.07.041
P577
2010-01-19T00:00:00Z